Month: September 2023

Hepsor P113 OÜ, an affiliate of Hepsor AS with a 45% shareholding, terminated the lease agreement with Novel Clinic Assets OÜ. Hepsor P113 OÜ owns a commercial building with a leasable area of ca 4,000 m2 in Tallinn, at Pärnu mnt 113, of which the terminated lease agreement was signed for 3,575 m2. The lease was terminated due to a significant violation of the terms of the lease by the tenant.The lessee is obliged to compensate Hepsor P113 OÜ for the damage caused by the termination of the agreement and the lessor holds various guarantees as collateral for compensating possible claims for damages. Liquid guarantees guarantee compensation for damages caused by an expired lease claim until February 2024. As Hepsor P113 OÜ has other claims against the lessee in addition to rent claims, the effect of the termination of the agreement on the...

Baker Hughes Venture Global Gastech 2023Baker Hughes Chairman and CEO Lorenzo Simonelli and Venture Global CEO Mike Sabel at Gastech 2023 in Singapore on Sept. 5, 2023.Long-term expansion plan will increase Venture Global’s production to more than 100 MTPA across its current and future projects both in and outside of LouisianaSINGAPORE, Sept. 04, 2023 (GLOBE NEWSWIRE) — Today, Venture Global LNG announced its long-term expansion plan to increase production from 70 million tonnes per annum (MTPA) to more than 100 MTPA of nameplate LNG export capacity. To support this initiative, Venture Global and Baker Hughes have executed an expanded master equipment supply agreement for the delivery of additional liquefaction train systems and power island systems for Venture Global’s future LNG export projects. The expanded agreement...

SUNNYVALE, Calif., Sept. 04, 2023 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the CL King 21st Annual Best Ideas Conference. Management is scheduled to present on Monday, September 18, 2023, at 8:45 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/. About Silk Road MedicalSilk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called...

 THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 (“MAR”).Solvay SA: liability management updateConsents on 2025 and 2027 Bonds Successful Tender on 2024 Hybrid Bonds Successful 2029 Bonds to be Redeemed, Trade under Review, No Bondholder MeetingBrussels, 4 September 2023 at 9.00pm CEST – As part of the consent solicitation announced on 4 August 2023 in relation to Solvay SA (“Solvay” or the “Company”)’s €600,000,000 0.500 per cent. Fixed Rate Bonds due 6 September 2029 (ISIN: BE6315847804) (the “2029 Bonds”), Solvay has become aware that votes cast in favor of the consent representing less than 3% of the total nominal amount may not have been validly exercised. At this stage,...

Company AnnouncementPhase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis Trial results to be submitted for presentation at a future medical meeting Genmab and Seagen to engage in discussions with regulatory authoritiesCOPENHAGEN, Denmark, and BOTHELL, Wash.; September 4, 2023 – Genmab A/S (Nasdaq: GMAB) and Seagen Inc. (Nasdaq: SGEN) announced today that the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on or after front-line therapy who received TIVDAK® (tisotumab vedotin-tftv), compared with chemotherapy alone, met its primary endpoint of overall survival (OS). An Independent Data Monitoring Committee determined that OS crossed the pre-specified efficacy boundary at interim...

Nokia CorporationStock Exchange Release4 September 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 04.09.2023 Espoo, Finland – On 4 September 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 250,191 3.75CEUX 79,299 3.75AQEU 27,302 3.75TQEX 19,208 3.76Total 376,000 3.75* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation...

Press release Paris, 04 September 2023   Orange successfully completes its inaugural sustainability-linked bond issuance for EUR 500M   Orange has successfully issued its first sustainability-linked bond, for a nominal amount of EUR 500 million, linked to the company’s target to reduce by -45% its absolute greenhouse gas emissions (Scope 1, 2 & 3) by 2030 (vs. 2020) and its commitment to provide digital support and training to external beneficiaries (6 million beneficiaries cumulatively between 2021 and 2030).   This GHG reduction target is aligned with the objective to keep global warming at 1.5°C and has been submitted to SBTi for validation.    Currency Format Term Notional Coupon Re-offer spreadEUR Fixed rate 2035 500 million 3.875% m/s + 72bps    This issuance follows Orange’s recently published Sustainability-Linked...